Mouse Anti-Rat RT1Bu (Class II Polymorphic) Monoclonal Antibody, Biotin Conjugated from AbD Serotec
Mouse Anti-Guinea Pig T-Cells, Pan Monoclonal Antibody, FITC Conjugated from AbD Serotec
Mouse Anti-Rabbit T LYMPHOCYTES Monoclonal Antibody, Unconjugated, Clone KEN-5 from AbD Serotec
Canine Serum from CHEMICON
Biology Products:(Date:12/1/2009)... Particularly in Alzheimer,s disease, nerve cell d...ew therapeutic options may possibly be derived fro...sm. These findings have been published in the curr...ence . Until only a few years ago, neurogenesis t...ed to be impossible in the adult brain. The textbo...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
(Date:12/1/2009)... In a world first, a Monash University-led interna...ay to boost the output of the next generation of s...n collaboration with colleagues from the universit...d tandem dye-sensitised solar cells with a three-f...red with previously reported tandem dye-sensitised...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Innovation puts next-generation solar cells on the horizon 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 1STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 3NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 1NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 2NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 3Gene Mutation Is Linked to Heart Muscle Disease 51799 1Gene Mutation Is Linked to Heart Muscle Disease 51799 2(Date:12/2/2009)..., JERUSALEM, Israel, December 2 /PRNewswire/...y evaluating the preclinical (animal study) safety...ines technology from Weill,Cornell Medical College...o,treat inherited anemias such as Cooley,s Anemia....technologies to expand, ex vivo,populations of st...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Ltd...ral JAK2 inhibitor, SB1518, at The American Societ... in New Orleans. ,, Data will be presented on t...on trial of SB1518 detailing its safety, tolerabil...ofile in dose levels ranging from 100 to 600 mg. T...
(Date:12/2/2009)... RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall...Company") (OTC Bulletin Board: EMDY), a leading,pr...rmula, milk powder and,soybean products in China, ...in the Spring issue of US Food & Drink Executi... 250,000 executives in the food and beverage indus...
(Date:12/2/2009)... NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Si...any") (NYSE: SCR ), a leading pharmaceutical com...g, and marketing of branded,generic and proprietar...05 of,its drugs have been included in China,s Nati...ssued by China,s Ministry of Human Resources and S...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3